It is well known that inflammation plays a key role in ageing.
Several studies have highlighted the positive impact of curcumin supplementation in metabolic diseases such as diabetes, neurodegenerative diseases such as Alzheimer’s or Parkinson’s, or cancers, the main common phenomenon of which is inflammation.
Also, in mice, several studies have shown the effectiveness of curcumin on three common types of cancer: colon, lung and prostate.
In all studies, tumour size was significantly reduced, and post-treatment survival was increased up to three times.
The most common explanation for this effect is that curcumin is able to regulate the expression of certain pro-cancer proteins by binding onto the genes encoding them.